Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.

Oncol Lett · 2022 · PMC8850961 · PMID 35251346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Notably, the administration of InterD was consistent regardless of the aggressiveness of the disease, and an increasing trend for the administration of InterD was observed depending on the systemic anticancer treatment.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.